Second Consultation Launched on NHS Funding for Alzheimer’s Treatments
The National Institute for Clinical Excellence (NICE) published further draft guidance for public consultation that continues to not recommend Alzheimer’s treatments donanemab and lecanemab. NICE…
Read more...